Rifampicin and distamycin A as inhibitors of Rous sarcoma virus reverse transcriptase.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001358:Avian Sarcoma Viruses / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D004254:DNA Nucleotidyltransferases / Q000037:antagonists & inhibitors*; D004279:DNA, Viral / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology; D006835:Hydrazones / Q000494:pharmacology; D007700:Kinetics; D009994:Osmolar Concentration; D010455:Peptides / Q000494:pharmacology*; D011758:Pyrroles / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D013942:Thymine Nucleotides / Q000378:metabolism; D014316:Tritium
D000900:Anti-Bacterial Agents; D004279:DNA, Viral; D006835:Hydrazones; D010455:Peptides; D011758:Pyrroles; D013942:Thymine Nucleotides; D014316:Tritium; D003609:Dactinomycin; D004254:DNA Nucleotidyltransferases; D012293:Rifampin